+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Naltrexone"

Addictions Therapeutics Global Market Report 2024 - Product Thumbnail Image

Addictions Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Opioid related disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid related disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Opioid Withdrawal Syndrome- - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Withdrawal Syndrome- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Opioid mu receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid mu receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Opioid Use Disorder Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Opioid Use Disorder Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
From
Loading Indicator

Naltrexone is a medication used to treat addiction disorders, such as alcohol and opioid dependence. It works by blocking the effects of opioids and reducing cravings for alcohol and opioids. Naltrexone is available in both oral and injectable forms, and is typically prescribed in combination with other therapies, such as counseling and lifestyle changes. It is also used to treat other conditions, such as gambling addiction and compulsive eating. Naltrexone is a widely used medication for addiction disorders, and is available in many countries around the world. It is generally well-tolerated, with few side effects. However, it is important to note that it is not a cure for addiction, and should be used in combination with other treatments. Some companies in the Naltrexone market include Mylan, Teva Pharmaceuticals, and Endo Pharmaceuticals. Show Less Read more